Cited by 441Fatty Acid Research and HealthLipid metabolism and biosynthesisSphingolipid Metabolism and Signaling

Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases

Open access
Bazan, Nicolas G., Molina, Miguel F., Gordon, William C.·2011·Annual Review of Nutrition

Abstract

Essential polyunsaturated fatty acids (PUFAs) are critical nutritional lipids that must be obtained from the diet to sustain homeostasis. Omega-3 and -6 PUFAs are key components of biomembranes and play important roles in cell integrity, development, maintenance, and function. The essential omega-3 fatty acid family member docosahexaenoic acid (DHA) is avidly retained and uniquely concentrated in the nervous system, particularly in photoreceptors and synaptic membranes. DHA plays a key role in vision, neuroprotection, successful aging, memory, and other functions. In addition, DHA displays anti-inflammatory and inflammatory resolving properties in contrast to the proinflammatory actions of several members of the omega-6 PUFAs family. This review discusses DHA signalolipidomics, comprising the cellular/tissue organization of DHA uptake, its distribution among cellular compartments, the organization and function of membrane domains rich in DHA-containing phospholipids, and the cellular and molecular events revealed by the uncovering of signaling pathways regulated by DHA and docosanoids, the DHA-derived bioactive lipids, which include neuroprotectin D1 (NPD1), a novel DHA-derived stereoselective mediator. NPD1 synthesis agonists include neurotrophins and oxidative stress; NPD1 elicits potent anti-inflammatory actions and prohomeostatic bioactivity, is anti-angiogenic, promotes corneal nerve regeneration, and induces cell survival. In the context of DHA signalolipidomics, this review highlights aging and the evolving studies on the significance of DHA in Alzheimer's disease, macular degeneration, Parkinson's disease, and other brain disorders. DHA signalolipidomics in the nervous system offers emerging targets for pharmaceutical intervention and clinical translation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1146/annurev.nutr.012809.104635

Cites

216 of 216 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [19]AveldaAveldaño MI Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes Biochemistry 1988 27 1229 39 3365383

Cited by

Sorted by citations

Authors
Bazan, N. G., Molina, M. F., & Gordon, W. C.
Affiliations
Louisiana State University Health Sciences Center New Orleans (US)
Venue
Annual Review of Nutrition
Published
2011-08-21
Volume
31
Issue
1
Pages
321-351
ISSN
  • 0199-9885 (ISSN-L)
  • 1545-4312
OpenAlex
W2130852003
Cited by
441
References
216
Citations by year
2026: 15 · 2025: 22 · 2024: 24 · 2023: 22 · 2022: 20 · 2021: 36 · 2020: 35 · 2019: 28 · 2018: 29 · 2017: 39 · 2016: 31 · 2015: 39 · 2014: 30 · 2013: 36 · 2012: 29
FWCI
3.85
Type
journal article
Language
en
Open access
Locations
  • Annual Review of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Eye Institute (EY005121, R01EY005121)
  • National Institute of Neurological Disorders and Stroke (NS 046741, R01NS046741)
  • National Center for Research Resources (P20RR016816, RR016816)
  • National Center for Complementary and Integrative Health (AT005909, RC2AT005909)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
docosahexaenoic acid, omega-3 fatty acids, docosanoids, neuroprotectin D1, neuroinflammation, aging, Alzheimer's disease, macular degeneration, Parkinson's disease, neurodegenerative diseases, membrane phospholipids, anti-inflammatory signaling, neurotrophins, oxidative stress, angiogenesis inhibition, corneal nerve regeneration
MeSH terms
Aging, Animals, Deficiency Diseases, Diet, Docosahexaenoic Acids, Fatty Acids, Essential, Gene Expression Regulation, Humans, Macular Degeneration, Neuritis, Signal Transduction, Neurodegenerative Diseases, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review